Proteomic analysis of stage i endometrial cancer tissue: Identification of proteins associated with oxidative processes and inflammation

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 586-594

  Maxwell, G Larry ^a,b,c   Hood, Brian L ^c   Day, Roger ^d   Chandran, Uma ^d   Kirchner, David ^e   Kolli, V S Kumar ^e   Bateman, Nicolas W ^d   Allard, Jay ^a,b   Miller, Caela ^a,b,c   Sun, Mai ^d   Flint, Melanie S ^d   Zahn, Chris ^f   Oliver, Julie ^b   Banerjee, Subhadra ^b   Litzi, Tracy ^b   Parwani, Anil ^d   Sandburg, Glenn ^g   Rose, Scott ^a   Becich, Michael J ^d   Berchuck, Andrew ^g   Kohn, Elise ^b   Risinger, John I ^h   Conrads, Thomas P ^b,c   more..

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e WINDBER RESEARCH INSTITUTE   (United States)

^f UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^g DUKE UNIVERSITY MEDICAL CENTER   (United States)

^h MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endometrial cancer; Laser capture microdissection; Proteomics; Stage I

Indexed keywords

CYTOCHROME C OXIDASE; LIPOCORTIN 1; LIPOCORTIN 2; PEROXIREDOXIN 1; PEROXIREDOXIN 3; PEROXIREDOXIN 4; PEROXIREDOXIN 5; PEROXIREDOXIN 6; PROHIBITIN; RIBOSOME PROTEIN;

ARTICLE; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; LASER MICRODISSECTION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TISSUE MICROARRAY; WESTERN BLOTTING;

CARCINOMA, ENDOMETRIOID; CHROMATOGRAPHY, LIQUID; CYSTADENOCARCINOMA, SEROUS; ENDOMETRIAL NEOPLASMS; FEMALE; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NEOPLASM STAGING; POSTMENOPAUSE; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY;

EID: 79957444066     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.031     Document Type: Article

References (45)

1. A. Jemal, R. Siegel, E. Ward, Y. Hao, J. Xu, and T. Murray Cancer statistics, 2008 CA Cancer J Clin 60 2010 277 300
2. S.M. Ueda, D.S. Kapp, M.K. Cheung, J.Y. Shin, K. Osann, and A. Husain Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and its potential impact on the increasing number of deaths Am J Obstet Gynecol 198 218 2008 198:218.e1-e6
3. G.L. Maxwell, M. Brown, C. Tian, and W. Brewster Racial disparity among patients with advanced/recurrent endometrial cancer: a GOG study Cancer 107 2006 2197 2205 (Pubitemid 44665654)
4. J. Risinger, G.L. Maxwell, G. Chandramouli, A. Jazaeri, O. Aprelikova, and T. Patterson Microarray analysis reveals distinct expression profiles among different histologic types of endometrial cancer Cancer Res 63 2003 6 11 (Pubitemid 36070410)
5. G.L. Maxwell, G.V. Chandramouli, L. Dainty, T.J. Litzi, A. Berchuck, and J.C. Barrett Microarray analysis of endometrial carcinomas and mixed mullerian tumors reveals distinct gene expression profiles associated with different histologic types of uterine cancer Clin Cancer Res 11 2005 4056 4066 (Pubitemid 40791569)
6. Q.J. Cao, T. Belbin, N. Socci, R. Balan, M.B. Prystowsky, and G. Childs Distinctive gene expression profiles by cDNA microarrays in endometrioid and serous carcinomas of the endometrium Int J Gynecol Pathol 23 2004 321 329 (Pubitemid 39299020)
7. S.E. Ferguson, A.B. Olshen, A. Viale, R.R. Barakat, and J. Boyd Stratification of intermediate-risk endometrial cancer patients into groups at high risk or low risk for recurrence based on tumor gene expression profiles Clin Cancer Res 11 2005 2252 2257 (Pubitemid 40490184)
8. G. Moreno-Bueno, C. Sánchez-Estévez, R. Cassia, S. Rodríguez-Perales, R. Díaz-Uriarte, and O. Domínguez Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas Cancer Res 63 2003 5697 5702 (Pubitemid 37187463)
9. S.E. Ferguson, A.B. Olshen, A. Viale, C.S. Awtrey, R.R. Barakat, and J. Boyd Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma Gynecol Oncol 92 2004 719 725 (Pubitemid 38183172)
10. G.L. Mutter, J.P. Baak, J.T. Fitzgerald, R. Gray, D. Neuberg, and G.A. Kust Global expression changes of constitutive and hormonally regulated genes during endometrial neoplastic transformation Gynecol Oncol 83 2001 177 185 (Pubitemid 33033052)
11. S.A. Saidi, C.M. Holland, D.P. Kreil, D.J. MacKay, D.S. Charnock-Jones, and C.G. Print Independent component analysis of microarray data in the study of endometrial cancer Oncogene 23 2004 6677 6683 (Pubitemid 39265532)
12. Y.F. Wong, T.H. Cheung, KWk Lo, S.F. Yim, N.S.S. Siu, and S.C.S. Chan Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling Oncogene 26 2007 1971 1982 (Pubitemid 46474633)
13. FIGO (INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS) FIGO news, Corpus cancer staging Int J Gynecol Obstet 28 1989 190
14. H. Liu, R.G. Sadygov, and J.R. Yates III A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal Chem 76 14 2004 4193 4201 (Pubitemid 38943698)
15. V. Patel, B.L. Hood, and A.A. Molinolo Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression Clin Cancer Res 14 4 2008 1002 1014 (Pubitemid 351302545)
16. J.D. Storey, and R. Tibshirani Statistical significance for genome wide studies Proc Natl Acad Sci USA 100 2003 9440 9445 (Pubitemid 37033947)
17. L.V. DeSouza, J. Grigull, S. Ghanny, V. Dubé, A.D. Romaschin, and T.J. Colgan Endometrial carcinoma biomarker discovery and verification using differentially tagged clinical samples with multidimensional liquid chromatography and tandem mass spectrometry Mol Cell Proteomics 6 2007 1170 1182 (Pubitemid 47099227)
18. I. Byrjalsen, P. Mose Larsen, S.J. Fey, L. Nilas, M.R. Larsen, and C. Christiansen Two-dimensional gel analysis of human endometrial proteins: characterization of proteins with increased expression in hyperplasia and adenocarcinoma Mol Hum Reprod 5 1999 748 756 (Pubitemid 29366873)
19. J.S. Fang, R.D. Gillies, and R.A. Gatenby Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression Semin Cancer Biol 18 2008 330 337
20. J.C. Moon, Y.S. Hah, W.Y. Kim, B.G. Jung, H.H. Jang, and J.R. Lee Oxidative stress-dependent structural and functional switching of a human 2-Cys peroxiredoxin isotype II that enhances HeLa cell resistance to H2O2-induced cell death J Biol Chem 280 2005 28775 28784 (Pubitemid 41105779)
21. A.C. Neumann, and Q. Fang Are peroxiredoxins tumor suppressors? Curr Opin Pharmacol 7 2007 375 380 (Pubitemid 47289263)
22. J.Y. Bae, S.J. Ahn, W. Han, and D.Y. Noh Peroxiredoxin I and II inhibit H2O2-induced cell death in MCF-7 cell lines J Cell Biochem 101 2007 1038 1045 (Pubitemid 47040883)
23. L. Nonn, M. Berggren, and G. Powis Increased expression of mitochondrial peroxiredoxin-3 (Thioredoxin Peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis Mol Cancer Res 1 2003 682 689 (Pubitemid 36870521)
24. S.S. Mukhopadhyay, K.S. Leung, M.J. Hicks, P.J. Hastings, H. Youssoufian, and S.E. Plon Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia J Cell Biol 175 2006 225 235 (Pubitemid 44631417)
25. A. Kropotov, V. Gogvadze, O. Shupliakov, N. Tomilin, V.B. Serikov, and N.V. Tomilin Peroxiredoxin V is essential for protection against apoptosis in human lung carcinoma cells Exp Cell Res 312 2006 2806 2815
26. P. Karihtala, A. Mantymiemi, S.W. Kang, V.L. Kinnula, and Y. Soini Peroxiredoxins in breast carcinoma Clin Cancer Res 9 2003 3418 3424 (Pubitemid 37082738)
27. C. Quan, E.J. Cha, H.L. Lee, K.H. Han, K.M. Lee, and W.J. Kim Enhanced expression of peroxiredoxin I and IV correlates with development, recurrence and progression of human bladder cancer J Urol 175 2006 1512 1516
28. Y.Y. Huo, G. Li, R.F. Duan, Q. Gou, C.L. Fu, and Y.C. Hu PTEN deletion leads to deregulation of antioxidants and increased oxidative damage in mouse embryonic fibroblasts Free Radic Biol Med 44 2008 1578 1591
29. C. Merkwirth, S. Dargazanli, T. Tatsuta, S. Geimer, B. Löwer, and F.T. Wunderlich Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondria Genes Dev 22 2008 476 488 (Pubitemid 351272755)
30. K. Kasashima, E. Ohta, Y. Kagawa, and H. Endo Mitochondrial functions and estrogen receptor-dependent nuclear translocation of pleiotropic human prohibitin 2 J Biol Chem 281 2006 36401 36410 (Pubitemid 46041374)
31. S.L. Simon, A. Parkes, E. Leygue, H. Dotzlaw, L. Snell, and S. Troup Expression of a repressor of estrogen receptor activity in human breast tumors: relationship to some known prognostic markers Cancer Res 60 2000 2796 2799 (Pubitemid 30395794)
32. J.L. Henry, D.L. Coggin, and C.R.L. King High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2 Cancer Res 53 1993 1403 1408 (Pubitemid 23097124)
33. G.F. Barnard, R.J. Staniunas, M. Mori, M. Puder, M.J. Jessup, and G.D. Steele Jr. Gastric and hepatocellular carcinomas do not over-express the same ribosomal protein messenger RNAs as colonic carcinoma Cancer Res 53 1993 4048 4052 (Pubitemid 23267709)
34. H. Wang, L.N. Zhao, K.Z. Li, R. Ling, X.J. Li, and L. Wang Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer BMC Cancer 11 6 2006 91
35. H. Kasai, D. Nadano, E. Hidaka, K. Higuchi, M. Kawakubo, and T.A. Sato Differential expression of ribosomal proteins in human normal and neoplastic colorectum J Histochem Cytochem 51 2003 567 574
36. M.H. Vaarala, K.S. Porvari, A.P. Kyllönen, M.V. Mustonen, O. Lukkarinen, and P.T. Vihko Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: confirmation of L7a and L37 over-expression in prostate-cancer tissue samples Int J Cancer 78 1998 27 32 (Pubitemid 28391670)
37. F. Wan, D.E. Anderson, R.A. Barnitz, A. Snow, N. Bidere, and L. Zheng Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation Cell 131 2007 927 939 (Pubitemid 350138085)
38. C.N. Serhan, and N. Chiang Novel endogenous small molecules as the checkpoint controllers in inflammation and resolution: entrée for resoleomics Rheum Dis Clin North Am 30 2004 69 95 (Pubitemid 38234769)
39. L. Parente, and E. Solito Annexin 1: more than an anti-phospholipase protein Inflamm Res 53 2004 125 132 (Pubitemid 38526595)
40. X.F. Bai, X.G. Ni, P. Zhao, S.M. Liu, H.X. Wang, and B. Guo Overexpression of annexin 1 in pancreatic cancer and its clinical significance World J Gastroenterol 10 2004 1466 1470 (Pubitemid 39206812)
41. S.H. Ahn, H. Sawada, J.Y. Ro, and G.L. Nicolson Differential expression of annexin I in human mammary ductal epithelial cells in normal and benign and malignant breast tissues Clin Exp Metastasis 15 1997 151 156 (Pubitemid 27157817)
42. C.Y. Lin, Y.M. Jeng, H.Y. Chou, H.C. Hsu, R.H. Yuan, and C.P. Chiang Nuclear localization of annexin A1 is a prognostic factor in oral squanous cell carcinoma J Surg Oncol 97 2008 544 550
43. K.L. Wang, T.T. Wu, E. Resetkova, H. Wang, A.M. Correa, and W.L. Hofstetter Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome Clin Cancer Res 12 2006 4598 4604 (Pubitemid 44297810)
44. A. Giatromanolaki, E. Sivridis, K.C. Gatter, H. Turley, A.L. Harris, and M.I. Koukourakis Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis Gynecol Oncol 103 2006 912 918 (Pubitemid 44821314)
45. M. Azuma, M. Shi, K.D. Danenberg, H. Gardner, C. Barrett, and C.J. Jacques Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients Pharmacogenomics 8 2007 1705 1713